Motor Activity: Clinical Trials

335 trials for Motor Activity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

238 completed, 45 unknown, 24 recruiting, 15 terminated. 335 Phase 2, 61 Phase 3, 55 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2335Completed 238, Unknown 45, Recruiting 24, Terminated 15, Active not recruiting 4, Not yet recruiting 4, Withdrawn 4, Enrolling by invitation 1
Phase 361Completed 45, Unknown 8, Recruiting 4, Terminated 2, Not yet recruiting 1, Withdrawn 1
Phase 155Completed 39, Unknown 9, Recruiting 4, Terminated 2, Not yet recruiting 1

Follow Motor Activity: new trials by email Literature Review of Motor Activity trials Research Report on Motor Activity

Trials (filtered) newest first · largest first

All 335 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial
testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries
Phase 2 / Phase 3Not yet recruitingVA Office of Research and Development3002027-10-012026-08-04
Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE)
Exercise, Duloxetine, Placebo - Knee Osteoarthritis, Pain
Phase 2Not yet recruitingVA Office of Research and Development1022027-03-012026-06-16
Partner4Exercise Study
Peer matching, Quailfied Exercise Professional (QEP) Support - Cancer
Phase 2 / Phase 3RecruitingMcMaster University1832026-09-012026-10-29
A Nutrition and Exercise Program With Olanzapine Compared to Olanzapine Alone: A Trial in Patients With Advanced Tumors
Standardized nutritional program, standardized exercize program, Whey protein supplement with added leucine and β-hydroxy-β-methylbutyrate (HMB) - Cancer, Advanced Solid Tumors, Malnutrition
Phase 2Not yet recruitingKantonsspital Winterthur KSW1302026-08-012026-07-27
Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS
Exercise - Parkinson's Disease, Deep Brain Stimulation
Phase 2RecruitingThe Cleveland Clinic362026-07-082026-10-26
Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial
(-)-Epicatechin-rich cocoa supplementation combined with exercise training, Placebo combined with exercise training - Mobility Disability
Phase 1 / Phase 2RecruitingUniversity of Alabama at Birmingham362026-04-212026-05-08
Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease
L-menthol, Placebo - Interstitial Lung Disease (ILD)
Phase 2RecruitingRegion Skane202026-04-132026-04-24
A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU
FXS5626 tablet, Placebo - Active Non-anterior, Non-infectious Uveitis
Phase 2RecruitingShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.402026-01-292026-10-15
Living Independence Through Functional Training
Task-oriented resistance exercise - Mobility Limitation, Cognitive Impairment
Phase 1 / Phase 2RecruitingUniversity of Florida152026-01-062026-07-31
Fasted vs. Fed State Exercise
16 week exercise intervention - Obesity, Exercise
Phase 2RecruitingArkansas Colleges of Health Education402026-01-052026-03-23
Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
Telehealth Exercise Program - Cancer-related Fatigue, Breast Cancer
Phase 2RecruitingUniversity of Colorado, Denver1342025-10-082026-02-05
Nurse-Led Elderly Sleep Intervention
Otago programme, Otago programme + Cognifit, Control - Sleep, Gerontology
Phase 1 / Phase 2CompletedUniversity of Castilla-La Mancha662025-09-012026-05-22
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Memantine, Placebo medication, Exercise Intervention - Breast Cancer, Locally Advanced Breast Cancer
Phase 2RecruitingUNC Lineberger Comprehensive Cancer Center902025-08-192026-05-06
A Mobile Intervention to Reduce Pain and Improve Health-III
MORPH, Measurement Only - Chronic Pain, Osteoarthritis
Phase 2RecruitingWake Forest University2002025-08-142026-02-20
Chronic Exogenous Ketosis in HFpEF
Exogenous Ketone Drink, Placebo - Heart Failure With Preserved Ejection Fraction (HFPEF), Heart Failure With Normal Ejection Fraction
Phase 2Enrolling by invitationDuke University202025-07-282026-10-14
VR-based Physical Activity and Reminiscence Therapy
aPAVRCT - Dementia, Neurodegenerative Disease
Phase 1 / Phase 2Not yet recruitingHong Kong University of Science and Technology1002025-05-192025-05-22
Effectiveness of a Personalized In-home Telerehabilitation Program on Self-Care in Patients With Long COVID
Education for self-management, Personalised exercise program, Usual Care - Long COVID Syndrome
Phase 2CompletedCEU San Pablo University572025-03-012026-10-08
Promoting Active Therapy: Path to Wellness
Walk-and-talk therapy - Depression, Anxiety, Physical Activity
Phase 2RecruitingKansas State University602025-02-282025-03-05
Heavy Strength Training in Head and Neck Cancer Survivors
Experimental - Head and Neck Neoplasms, Head and Neck Cancer
Phase 2CompletedUniversity of Alberta372025-02-172026-08-12
Response to Exercise and Nitric Oxide in PAD
Supervised Treadmill Exercise, Attention Control, Nitrate-Rich Beetroot Juice + supervised exercise therapy - Peripheral Artery Disease, Exercise
Phase 2RecruitingNorthwestern University2002025-01-232026-07-27

Showing 20 of 335. Sign in to see all of them.

Narrower conditions

Obesity (35)  ·  Diabetes Mellitus (14)  ·  Osteoarthritis (14)  ·  Sedentary Behavior (13)  ·  Breast Neoplasms (12)  ·  Overweight (12)  ·  Stroke (12)  ·  Cardiovascular Diseases (11)  ·  Pain (11)  ·  Depression (10)  ·  Diabetes Mellitus, Type 2 (10)  ·  Neoplasms (10)  ·  Insulin Resistance (9)  ·  Pulmonary Disease, Chronic Obstructive (9)

Broader conditions

Behavior (332)  ·  Pathological Conditions, Signs and Symptoms (122)  ·  Signs and Symptoms (91)  ·  Nutritional and Metabolic Diseases (75)  ·  Nervous System Diseases (53)  ·  Musculoskeletal Diseases (49)  ·  Metabolic Diseases (44)  ·  Cardiovascular Diseases (42)  ·  Pathologic Processes (41)  ·  Body Weight (37)  ·  Neoplasms (37)  ·  Neurologic Manifestations (37)  ·  Nutrition Disorders (37)  ·  Overnutrition (36)  ·  Neoplasms by Site (35)

Interventions

Exercise (82)  ·  Resistance Training (11)  ·  Diet (7)  ·  Health (4)  ·  Methods (4)  ·  Nutrition Assessment (4)  ·  formic acid 4-(3-oxobutyl)phenyl ester (4)  ·  Lidocaine (3)  ·  Muscle Stretching Exercises (3)  ·  Tadalafil (3)  ·  Testosterone (3)  ·  Therapeutics (3)  ·  Autogenic Training (2)  ·  Behavior Therapy (2)  ·  Curcumin (2)

Sponsors

University of Alberta (10)  ·  VA Office of Research and Development (10)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (7)  ·  Duke University (6)  ·  Northwestern Health Sciences University (6)  ·  Centers for Disease Control and Prevention (5)  ·  Charite University, Berlin, Germany (5)  ·  Stanford University (5)  ·  University of Florida (5)  ·  National Heart, Lung, and Blood Institute (NHLBI) (4)  ·  Oregon Health and Science University (4)  ·  The Miriam Hospital (4)  ·  University Health Network, Toronto (4)  ·  University of Texas Southwestern Medical Center (4)  ·  Colorado State University (3)

Countries

United States (180)  ·  Canada (39)  ·  Germany (21)  ·  Denmark (13)  ·  United Kingdom (13)  ·  Spain (12)  ·  France (8)  ·  Netherlands (8)  ·  Belgium (6)  ·  Sweden (6)  ·  Brazil (5)  ·  Australia (4)  ·  Switzerland (4)  ·  China (3)  ·  Norway (3)

Top investigators

Gert Bronfort, DC, PhD (4)  ·  Jennifer M Hootman, PhD (4)  ·  Christopher Bell, PhD (3)  ·  Shabbir MH Alibhai, MD, MSc (3)  ·  Andrew Redington, MD (2)  ·  Bess H Marcus, PhD (2)  ·  Bruce Dobkin, MD (2)  ·  David M Williams, Ph.D. (2)  ·  Fernando Dimeo, MD (2)  ·  Gordon J Bell, PhD (2)  ·  Joshua F Yarrow, PhD MS BS (2)  ·  Kerry Courneya, PhD (2)  ·  Kerry S Courneya, PhD (2)  ·  Kim L Bennell, PhD (2)  ·  Lori Pbert, PhD (2)

Results publications

PMID 17877825, PMID 22772084, PMID 29976553, PMID 35588252, PMID 36602886, PMID 37162250, PMID 38588457, PMID 10582706, PMID 10836297, PMID 11852377, PMID 12037511, PMID 12448827, PMID 12746623, PMID 12846028, PMID 1515244, PMID 15405683, PMID 15963313, PMID 16919322, PMID 16968322, PMID 17013851, PMID 17133529, PMID 17135615, PMID 17167156, PMID 17453366, PMID 17502536, PMID 17557948, PMID 18163409, PMID 18234327, PMID 18274222, PMID 18316660, PMID 18582371, PMID 18840807, PMID 19242554, PMID 19459233, PMID 19643946, PMID 19698154, PMID 19734776, PMID 19750190, PMID 19777141, PMID 19781877, PMID 19919718, PMID 19934630, PMID 19944914, PMID 19997004, PMID 20012639, PMID 20067626, PMID 20193083, PMID 20205704, PMID 20528109, PMID 20531162

NIH funding

2016 (2), 2017 (2), 2015 (1), 2023 (1), 75N91021C00019-0-9999-1 (1), F32AG074680 (1), I01CX002543 (1), I01RX001449 (1), I01RX001507 (1), K01AG025962 (1), K01HL161419 (1), K23AG086604 (1), K23DA019950 (1), K23HL161348 (1), KL2TR002492 (1)